AI Science Tracker
EN

Machine learning-enabled spatial multi-omics uncovers lactate-driven targets and tumor microenvironmental reprogramming in cancer.

Zhuzhou Hospital, Central South University; Tumor ImmunoMetabolism Institute, Zhuzhou Hospital · 30 Dec 2025 · biology

Discovery

Machine learning-enabled spatial multi-omics uncovers lactate-driven targets and tumor microenvironmental reprogramming in cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding: Integrated spatial and single-cell multi-omics with machine-learning analyses found different cell-type patterns in high- and low-lactate lung adenocarcinoma samples, with selected programs associated with survival. Spatial metabolomics and immunofluorescence provide supporting measurements; these are observational associations and do not establish lactate as a causal driver or therapeutic target.

Technology: Machine-learning analysis integrates spatial, single-cell, and molecular measurements to identify tumor-microenvironment associations.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Machine-learning integration prioritized cell-type and molecular associations linked to lactate states and clinical outcomes.
Test and result
High-lactate samples showed greater epithelial and fibroblast abundance, while low-lactate samples had more T/NK cells and monocytes/macrophages; selected programs associated with survival.
Limitation / still unknown
Spatial measurements and survival associations are observational; no causal lactate effect or therapeutic benefit is demonstrated.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12864923/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full-text Methods and Results; version date and reported validation scope checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.